article thumbnail

Orforglipron: the new kid on the GLP-1 block

Lloyd Price

Exec Summary: Orforglipron was originally discovered and developed by Chugai Pharmaceutical Co., Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk

article thumbnail

Abu Dhabi Global Healthcare Week: What are the key talking points likely to be?

Lloyd Price

In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.

article thumbnail

PointClickCare Announces Brian Drozdowicz as Senior Vice President and General Manager of Acute & Payer Markets

Digital Health Global

In his role, Brian will serve as an important member of the senior leadership team, responsible for the development and continued success of Health System, Health Plan and Convener markets, and for driving value in PointClickCare’s connected care network. We are excited to welcome him into this critical leadership position for the company.”

article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

“He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions. Colin has demonstrated strong leadership to his teams and customers alike.” “I Colin is a proven leader with a deep understanding of the digital health technology industry.

BioTech 88
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.